Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 May 24;63(6):e00593-19.
doi: 10.1128/AAC.00593-19. Print 2019 Jun.

Reply to Banda et al., "Interpretation of Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine"

Affiliations
Comment

Reply to Banda et al., "Interpretation of Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine"

Stephen Walimbwa et al. Antimicrob Agents Chemother. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Kakuda TN, Opsomer M, Timmers M, Iterbeke K, Van De Casteele T, Hillewaert V, Petrovic R, Hoetelmans RM. 2014. Pharmacokinetics of darunavir in fixed‐dose combination with cobicistat compared with coadministration of darunavir and ritonavir as single agents in healthy volunteers. J Clin Pharmacol 54:949–957. doi:10.1002/jcph.290. - DOI - PubMed
    1. Davies NM, Takemoto JK, Brocks DR, Yanez JA. 2010. Multiple peaking phenomena in pharmacokinetic disposition. Clin Pharmacokinet 49:351–377. doi:10.2165/11319320-000000000-00000. - DOI - PubMed
    1. Castellino S, Moss L, Wagner D, Borland J, Song I, Chen S, Lou Y, Min SS, Goljer I, Culp A, Piscitelli SC, Savina PM. 2013. Metabolism, excretion, and mass balance of the HIV-1 integrase inhibitor dolutegravir in humans. Antimicrob Agents Chemother 57:3536–3546. doi:10.1128/AAC.00292-13. - DOI - PMC - PubMed

LinkOut - more resources